ACIUHealthcareBiotech — CHF reporting·Sep 3, 2026·1 min read

ACIU: FY25 Deep Dive

AC Immune FY25 at CHF 4M. NI CHF -67M; EPS CHF -0.67.

ACIU: FY25 Deep Dive

FY25 revenue CHF 4M; OI CHF -69M; NI CHF -67M; EPS CHF -0.67.

AC Immune FY25 (Dec 31, 2025 (currency: CHF)) at CHF 4M revenue. OpInc CHF -69M; NI CHF -67M; EPS CHF -0.67. Biotech — CHF reporting.

Related:ACIU

Want deeper analysis?

Ask drillr anything about ACIU — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free